Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study
Matthew R. D’Costa(Hypertension Institute), Andrew D. Rule(Mayo Clinic), Felicity Enders(Mayo Clinic), John C. Lieske(Mayo Clinic), Cynthia H. McCollough(Mayo Clinic in Arizona), William E. Haley(Jacksonville College), Kristin C. Mara(Mayo Clinic), Steven J. Jacobsen(Mayo Clinic), Terri J. Vrtiska(Mayo Clinic), Vernon M. Pais(Dartmouth–Hitchcock Medical Center)
Cited by 112
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
|JAMA|2016|1.2k
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #
|Hepatology|2009|721
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
An estimated glomerular filtration rate equation for the full age spectrum
|Nephrology Dialysis Transplantation|2016|489